Eur Respir J 2003; 21:294-302
Copyright ©ERS Journals Ltd 2003
Community-acquired pneumonia in the elderly: Spanish multicentre study
R. Zalacain1,
A. Torres2,
R. Celis2,
J. Blanquer3,
J. Aspa4,
L. Esteban5,
R. Menéndez6,
R. Blanquer7 and
L. Borderías8 on behalf of the "Pneumonia in the elderly" working group, Area de Tuberculosis e Infecciones Respiratorias
1 Servicio de Neumología, Hospital de Cruces, Bilbao, 2 Servei de Pneumología i Allèrgia Respiratoria, Institut Clínic de Pneumologia i Cirurgía Torácica, Hospital Clinic, Barcelona, 3 Unidad de Cuidados Intensivos Respiratorios, Hospital Clínico, Valencia, 4 Servicio de Neumología, Hospital La Princesa, Madrid, 5 Sección de Neumología, Hospital Mutua Terrassa, Barcelona, 6 Servicio de Neumología, Hospital La Fé, Valencia, 7 Servicio de Neumología, Hospital Dr Peset, Valencia, and 8 Sección de Neumología, Hospital San Jorge, Huesca, Spain
CORRESPONDENCE: TorresR. Zalacain, Secretaría SEPAR (Area TIR), Balmes 68 Pral, 08007, Barcelona, Spain. Fax: 34 934878509. E-mail: ssepar@separ.es
Keywords: aetiology, clinical characteristics, community-acquired pneumonia, elderly, prognostic factors
Received: July 17, 2002
Accepted October 15, 2002
This study was sponsored by the "Area de Tuberculosis e Infecciones Respiratorias (TIR)", Sociedad Española de Neumología y Cirugía Torácica (SEPAR) and Aventis.
Community-acquired pneumonia (CAP) in the elderly has increased as a consequence of an overall increase of the elderly population. A controversy about the aetiology and outcome of CAP in this population still exists and more epidemiological studies are needed.
A prospective, 12-month, multicentre study was carried out to assess the clinical characteristics, aetiology, evolution and prognostic factors of elderly patients ( 65 yrs) admitted to hospital for CAP. The study included 503 patients (age 76±7 yrs).
The clinical picture lasted 5 days in 318 (63%) and the main clinical features were cough (n=407, 81%) and fever (n=380, 76%). Aetiological diagnosis was achieved in 199 (40%) cases, with a definite diagnosis obtained in 164 (33%). Of the 223 microorganisms isolated the main agents found were Streptococcus pneumoniae in 98 (49%) and Haemophilus influenzae in 27 (14%). A total of 53 patients died (11%) and the multivariate analysis showed the following factors of bad prognosis: previous bed confinement, alteration in mental status, absence of chills, plasma creatinine 1.4 mg·dL1, oxygen tension in arterial blood/inspiratory oxygen fraction ratio <200 at the time of admission, and shock and renal failure during the evolution.
The results of this study may aid in the management of empiric antibiotic treatment in elderly patients with community-acquired pneumonia and the patients who have a greater probability of bad evolution may be identified based on the risk factors.
This article has been cited by other articles:

|
 |

|
 |
 
H. Kothe, T. Bauer, R. Marre, N. Suttorp, T. Welte, K. Dalhoff, and the Competence Network for Community-Acquired Pneu
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment
Eur. Respir. J.,
July 1, 2008;
32(1):
139 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Valencia, J. R. Badia, M. Cavalcanti, M. Ferrer, C. Agusti, J. Angrill, E. Garcia, J. Mensa, M. S. Niederman, and A. Torres
Pneumonia Severity Index Class V Patients With Community-Acquired Pneumonia: Characteristics, Outcomes, and Value of Severity Scores
Chest,
August 1, 2007;
132(2):
515 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Falguera, R. Pifarre, A. Martin, A. Sheikh, and A. Moreno
Etiology and Outcome of Community-Acquired Pneumonia in Patients With Diabetes Mellitus
Chest,
November 1, 2005;
128(5):
3233 - 3239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Waterer, L. A. Kessler, and R. G. Wunderink
Medium-Term Survival after Hospitalization with Community-Acquired Pneumonia
Am. J. Respir. Crit. Care Med.,
April 15, 2004;
169(8):
910 - 914.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the European Respiratory Society.
|